title: [Women and epilepsy].
abstract: Women with epilepsy have several gender-specific problems, first of all related to pregnancy and childbirth. They do, however, also meet with several other, less well-recognised specific problems. Many women have a marked change in seizure frequency in relation to their menstrual cycle, and menstrual disorders and polycystic ovaries induced by the use of antiepileptic drugs (AEDs), or by the condition itself, are more frequent in women with epilepsy. Cosmetic side effects of AEDs including weight gain, hair loss and skin problems can significantly reduce compliance in drug treatment and thus affect seizure frequency. Enzyme-inducing AEDs reduce the effectiveness of oral contraceptives and may lead to unplanned pregnancies. A higher incidence of sexual problems in women with epilepsy has also been reported. In menopause, the seizure frequency may change in parallel with the endocrine changes and some AEDs may facilitate the development of osteoporosis. Better understanding and awareness of these problems among patients and health care professionals can relieve many of the gender-specific problems in women. The goal is to tailor the treatment to the needs of the individual woman.
authors.affiliation: Nevrologisk avdeling, Rikshospitalet, Oslo. Rerik.tauboll@rikshospitalet.no
authors.forename: Erik
authors.initials: E
authors.lastname: Taubøll
authors.forename: Leif
authors.initials: L
authors.lastname: Gjerstad
authors.forename: Tore
authors.initials: T
authors.lastname: Henriksen
authors.forename: Henrik
authors.initials: H
authors.lastname: Husby
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D008593:Menopause; D008598:Menstruation; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000503:physiopathology; D012737:Sex Factors; D019529:Sexuality; D016387:Women's Health
chemical_list: D000927:Anticonvulsants